Sutro Biopharma CMO Arturo Molina resigns; effective Nov 4, 2022

SUTRO BIOPHARMA, INC.

Dr. Arturo Molina notified Sutro on Oct 18, 2022 of his resignation as Chief Medical Officer.
Resignation effective November 4, 2022; no successor announced.
Company states resignation not due to any disagreement with management or board.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Arturo Molina

Chief Medical Officer

STRO · SUTRO BIOPHARMA, INC.

Effective: 2022-11-04
Filed: October 24, 2022, 7:59 PM ET

On October 18, 2022, Dr. Arturo Molina notified Sutro Biopharma, Inc. (the “ Company ”) that he will resign from his role as Chief Medical Officer of the Company, effective November 4, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Arturo Molina resigned as Chief Medical Officer at SUTRO BIOPHARMA, INC..

Action: resigned
Role: Chief Medical Officer

Exact text from the filing

On October 18, 2022, Dr. Arturo Molina notified Sutro Biopharma, Inc. (the “ Company ”) that he will resign from his role as Chief Medical Officer of the Company, effective November 4, 2022.

View on SEC.gov

SUTRO BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0000950170-22-019872

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.